WooGene B&G Co., Ltd (KOSDAQ:018620)
South Korea · Delayed Price · Currency is KRW 2,720.00
+5.00 (0.18%)
At close: Sep 11, 2026
WooGene B&G Market Cap
WooGene B&G has a market cap or net worth of 18.86 billion as of September 11, 2026. Its market cap has decreased by -32.91% in one year.
Market Cap
18.86B
Enterprise Value
68.22B
Revenue
56.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,720.00
ChartMarket Cap Chart
Since May 20, 2008, WooGene B&G's market cap has increased from 18.33B to 18.86B, an increase of 2.90%. That is a compound annual growth rate of 0.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 18.86B | -21.45% |
| Dec 30, 2025 | 24.01B | -6.10% |
| Dec 30, 2024 | 25.57B | -27.76% |
| Dec 28, 2023 | 35.39B | -20.45% |
| Dec 29, 2022 | 44.49B | -26.67% |
| Dec 30, 2021 | 60.66B | -23.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmsville | 28.13B |
| HLscience | 27.15B |
| Daesung Microbiological Labs. | 23.41B |
| Baskhanbio Pharma | 23.30B |
| Seoul Pharma | 22.81B |
| BIFIDO | 22.45B |
| Hurum | 20.59B |
| Union Korea Pharm | 19.70B |